Cargando…
Comment on “The efficiency of risedronate in reducing bone resorption after total hip arthroplasty: a meta-analysis of randomized control trials at a minimum of 6 months’ follow-up”
Autores principales: | Kai Huang, M. M., Gang Wang, M. M., Yi Zeng, M. D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003973/ https://www.ncbi.nlm.nih.gov/pubmed/35414097 http://dx.doi.org/10.1186/s13018-022-03118-0 |
Ejemplares similares
-
The efficiency of risedronate in reducing bone resorption after total hip arthroplasty: a meta-analysis of randomized control trials at a minimum of 6 months’ follow-up
por: Yang, Liqing
Publicado: (2018) -
Monthly minodronate inhibits bone resorption to a greater extent than does monthly risedronate
por: Kamimura, Mikio, et al.
Publicado: (2016) -
Letter to the Editor: Oral risedronate increases Gruen zone bone mineral density after primary total hip arthroplasty: a meta-analysis
por: Huang, Kai, et al.
Publicado: (2022) -
Efficacy of risedronate in improving bone mineral density in patients undergoing total hip arthroplasty: A meta-analysis of randomized controlled trials
por: Su, Jing, et al.
Publicado: (2018) -
Oral risedronate increases Gruen zone bone mineral density after primary total hip arthroplasty: a meta-analysis
por: Li, Qifeng, et al.
Publicado: (2018)